<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/868E2BB5-A9CE-46B4-94E1-7B415B1E6DDE"><gtr:id>868E2BB5-A9CE-46B4-94E1-7B415B1E6DDE</gtr:id><gtr:firstName>Paolo</gtr:firstName><gtr:surname>Camici</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U120084164"><gtr:id>C17A6F87-B3F9-44A8-A23C-9E11947C6426</gtr:id><gtr:title>Cardiology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U120084164</gtr:grantReference><gtr:abstractText>An increasing number of patients in the UK develop heart failure. Heart failure accounts for approximately 20% of all hospital admissions amongst people over 65 and in the past 10 years the hospitalization rate has increased by ~160%. The mortality for patients treated with drugs continues to be very high with annual rates between 20 and 45%.In over 70% of patients heart failure is secondary disease of the coronary arteries, the vessels which carry blood to the heart muscle. In these patients heart failure is due the loss of contraction resulting from scar tissue and/or hibernating myocardium, a condition in which cardiac muscle does not contract properly, but is still alive. Reopening these vessels by surgery or catheters improves function of hibernating myocardium, heart failure symptoms and patients live longer.||Our research has significantly contributed to improve the diagnosis and treatment of heart failure. We have validated a new imaging tool based on a special scan of the heart which permits the identification of myocardial hibernation. We have established a diagnostic service here at the Hammersmith and referrals are received from Greater London and Southern England. Identification of this condition contributes to the decision of whether or not to procede with surgery. Therefore, this scan can contribute to significantly reduce the number of unnecessary operations.</gtr:abstractText><gtr:technicalSummary>The remit of our reserch programme is to carry out mechanistic studies in animals and patients to gain further insight into the pathophysiology of myocardial stunning, hibernation and post-ischaemic heart failure and to test new pharmacological treatments. This requires the development of new methodology for positron emission tomography (PET) and cardiac magnetic resonance (CMR) necessary for studies in patients and animals. Furthermore, we carry out ex vivo studies in patients and animals to gain further insights into the molecular mechanisms of these conditions.||Ischaemic heart disease is the number one killer in the UK. As the mortality associated with acute coronary syndromes continues to decline, an increasing number of patients survive and develop congestive heart failure. Heart failure accounts for approximately 20% of all hospital admissions amongst people over 65 and in the past 10 years the hospitalization rate has increased by ~160%. Although a number large randomized trials have demonstrated a significant reduction in mortality for patients treated medically, symptomatic heart failure continues to have a one-year mortality close to 45%.||In over 70% of the cases heart failure is secondary to ischaemic heart disease. In these patients heart failure is due the loss of contraction resulting from scar tissue and/or hibernating myocardium, a condition in which cardiac muscle, subtended by a stenotic coronary artery, is chronically dysfunctional, but still viable. Coronary revascularization improves function of hibernating myocardium, heart failure symptoms and prognosis.||We have demonstrated that resting flow to hibernating myocardium is not reduced (as initially hypothesised), but that this condition is characterised by a severe limitation of the coronary flow reserve (the ability of the heart to increase its blood supply to meet an increased demand). Subsequent studies by our group have led to a new pathogenetic hypothesis: 1- a severe limitation of flow reserve leads to low threshold demand ischaemia; 2- each ischaemic episode is followed by myocardial dysfunction (stunning); 3- repetitive episodes of ischaemia lead to chronic stunning (hibernation). Recently, we have identified the cellular mechanisms of hibernating myocardium which allow its prolonged survival. More recently, we have demonstrated that human hibernating myocardium is characterized by an upregulation of genes and corresponding proteins involved in anti-apoptosis (IAP), growth (VEGF, H11 kinase) and cytoprotection (HSP70, HIF-1?, GLUT1). These changes characterize viable tissue, as they were not found in irreversibly injured myocardium and demonstrate a novel mechanism by which the activation of an endogenous gene program of cell survival underlies the sustained viability of the hibernating heart. Our research has significantly contributed to improve the diagnosis and treatment of heart failure. We have validated a new imaging tool based on PET for the identification of myocardial hibernation and have established a diagnostic service here at the Hammersmith and referrals are received from Greater London and Southern England. Identification of this condition contributes to the optimisation of treatment in these patients (i.e. whether or not to procede with coronary revascularisation which is associated with higher peri-operative mortality in patients with very low ejection fraction) which can significantly reduce the number of unnecessary bypass operations and percutaneous coronary interventions.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-07-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>9384601</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>68E5978A-A4D0-4DCA-AF6B-E867C670C90D</gtr:id><gtr:title>Pre- and post-synaptic sympathetic function in human hibernating myocardium.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fca7f87f0db8e3dfbaab2dc108396c8a"><gtr:id>fca7f87f0db8e3dfbaab2dc108396c8a</gtr:id><gtr:otherNames>John AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>5B5DA2A5F59</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4171CD3-2FF0-471B-B51E-6EE42480EA1A</gtr:id><gtr:title>Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ee620a604796cefbdadcdc07ad0ab1a"><gtr:id>2ee620a604796cefbdadcdc07ad0ab1a</gtr:id><gtr:otherNames>Naoumova RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>3F86516EB69</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD21642F-7EF4-4FE9-A3EA-FA5FE9F08378</gtr:id><gtr:title>Myocardial blood flow measurement by PET: technical aspects and clinical applications.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/999ff6d32c66303bc88979aae30c4c70"><gtr:id>999ff6d32c66303bc88979aae30c4c70</gtr:id><gtr:otherNames>Kaufmann PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>7DFF8C98413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D43FB40-3B13-4698-90F2-7ECA876E3C24</gtr:id><gtr:title>Cardiac nociception.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>45AE9801678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EA3F465-A1B2-4EAF-88B8-5DF4CD0019E5</gtr:id><gtr:title>Comparison of myocardial blood flow and coronary flow reserve during dobutamine and adenosine stress: Implications for pharmacologic stress testing in coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66e42708c02a833015bb7124c42723ae"><gtr:id>66e42708c02a833015bb7124c42723ae</gtr:id><gtr:otherNames>Jagathesan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1071-3581</gtr:issn><gtr:outcomeId>A9FF2ABFD25</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2045144C-9A97-4D99-8DE9-439365549B14</gtr:id><gtr:title>A novel (18)F-labeled tracer for the quantification of myocardial blood flow and infarct size with positron-emission tomography: another way to avoid the need of an on-site cyclotron.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>3618A643346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>856A00BE-C815-4303-AAB8-77422BB16D37</gtr:id><gtr:title>Program of cell survival underlying human and experimental hibernating myocardium.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14b1c774c3bb43ba9fe6aebffae47bb8"><gtr:id>14b1c774c3bb43ba9fe6aebffae47bb8</gtr:id><gtr:otherNames>Depre C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>DC90898C2FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E28B9439-70ED-42E8-B765-52556336749E</gtr:id><gtr:title>Myocardial stunning is associated with impaired calcium uptake by sarcoplasmic reticulum.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22e459c4c42360108e16cea2f07aec37"><gtr:id>22e459c4c42360108e16cea2f07aec37</gtr:id><gtr:otherNames>Kumar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>BC7D01AD7EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF34B7B6-37F0-4665-AD3A-75F4DC4C430C</gtr:id><gtr:title>The case for myocardial ischemia in hypertrophic cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bacf45fc24575a8127f31eb08d1975e"><gtr:id>7bacf45fc24575a8127f31eb08d1975e</gtr:id><gtr:otherNames>Maron MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>326E27018B7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D175C7D-AE3F-4C8A-967A-1F6EC54EB651</gtr:id><gtr:title>The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular function.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04fb9a42fe15b5437b018c26147ed865"><gtr:id>04fb9a42fe15b5437b018c26147ed865</gtr:id><gtr:otherNames>Pitt M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>D388468E8D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AA74F8F-4358-42E1-9B48-C7FE54578713</gtr:id><gtr:title>Respiratory gating of cardiac PET data in list-mode acquisition.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb13b928b3847b5b840d9257e07f58bd"><gtr:id>eb13b928b3847b5b840d9257e07f58bd</gtr:id><gtr:otherNames>Livieratos L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>D51FE78DCE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7582D05-5E48-4BF3-A002-91A479D9B9C4</gtr:id><gtr:title>[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC].</gtr:title><gtr:parentPublicationTitle>Kardiologia polska</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1848ae36826f5056bb883025138472a1"><gtr:id>1848ae36826f5056bb883025138472a1</gtr:id><gtr:otherNames>Silber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-9032</gtr:issn><gtr:outcomeId>3D2C09331CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C62A3F4C-B779-49A6-BFB6-C035D30A5B8F</gtr:id><gtr:title>Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43593c5eaee280ef08d59c1a9770eded"><gtr:id>43593c5eaee280ef08d59c1a9770eded</gtr:id><gtr:otherNames>Cook SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>3CE622CA238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1FFB027-57C7-446E-870F-54BBF475A0C7</gtr:id><gtr:title>Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/282b7ca6ec2c94a0461b974eed69ef13"><gtr:id>282b7ca6ec2c94a0461b974eed69ef13</gtr:id><gtr:otherNames>Olivotto I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>8C59557CB8D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59E8DFB6-075E-40D3-803B-630FBE934FE6</gtr:id><gtr:title>[Guidelines for percutaneous coronary interventions].</gtr:title><gtr:parentPublicationTitle>Revista espanola de cardiologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1848ae36826f5056bb883025138472a1"><gtr:id>1848ae36826f5056bb883025138472a1</gtr:id><gtr:otherNames>Silber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0300-8932</gtr:issn><gtr:outcomeId>85C91288B3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E4D3640-F96E-49AF-A190-0509FA279BBA</gtr:id><gtr:title>Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d604497e66a66d3eb02a57da1a75144"><gtr:id>2d604497e66a66d3eb02a57da1a75144</gtr:id><gtr:otherNames>Mongillo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>327F4D96EDA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ABF2B8F-EE81-4752-9D60-7B6E9ED5BD40</gtr:id><gtr:title>Positron emission tomography for quantitation of myocardial perfusion.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1170e3a78eba7bd406bfd603bf9bed49"><gtr:id>1170e3a78eba7bd406bfd603bf9bed49</gtr:id><gtr:otherNames>Rimoldi OE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1071-3581</gtr:issn><gtr:outcomeId>35F243DF32F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDAD0484-CC2B-487A-8173-D6C942709B18</gtr:id><gtr:title>Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Heart and circulatory physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/999ff6d32c66303bc88979aae30c4c70"><gtr:id>999ff6d32c66303bc88979aae30c4c70</gtr:id><gtr:otherNames>Kaufmann PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0363-6135</gtr:issn><gtr:outcomeId>E13E7302458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAA705D6-87E2-49BE-A014-694780A121A8</gtr:id><gtr:title>From microcirculation to cardiac event: protection with Preterax.</gtr:title><gtr:parentPublicationTitle>Journal of hypertension. Supplement : official journal of the International Society of Hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0952-1178</gtr:issn><gtr:outcomeId>BBEB3CD94BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8286FC2-8832-4823-A85A-E359D99FA845</gtr:id><gtr:title>Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f003bffb4ac485fe91bb0d9c2c7d6c9"><gtr:id>7f003bffb4ac485fe91bb0d9c2c7d6c9</gtr:id><gtr:otherNames>Kies P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>DA2422EC7CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC291211-4F75-4D8A-A83C-2802397DB090</gtr:id><gtr:title>Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e9217adb4bc21cecfb95f0508cad7b7"><gtr:id>2e9217adb4bc21cecfb95f0508cad7b7</gtr:id><gtr:otherNames>Gamble SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>FCB6E0F330D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E9A5FFE-6910-4DE2-85FA-A3D228821AD2</gtr:id><gtr:title>Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a730a679f56681d5b1ccfab63fdd7ac1"><gtr:id>a730a679f56681d5b1ccfab63fdd7ac1</gtr:id><gtr:otherNames>Hernandez-Pampaloni M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>4412D3AA7C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>015FD0CF-C676-45AD-A253-1E51BF87DC07</gtr:id><gtr:title>The clinical value of myocardial blood flow measurement.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>7EA02722A92</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E234F9D-128F-409B-8595-1FE86F53E815</gtr:id><gtr:title>Correction de mouvement respiratoire en TEP/TDM</gtr:title><gtr:parentPublicationTitle>M?decine Nucl?aire</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0434ded32d6852fe68c8cd0aa45e0d59"><gtr:id>0434ded32d6852fe68c8cd0aa45e0d59</gtr:id><gtr:otherNames>Visvikis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>291F499B13D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5739659F-3667-4247-99B6-C1F400057A6F</gtr:id><gtr:title>The contribution of hibernation to heart failure.</gtr:title><gtr:parentPublicationTitle>Annals of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0785-3890</gtr:issn><gtr:outcomeId>9EA0567BE80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEE3872D-B2E6-49CC-BE11-2C5853E078C2</gtr:id><gtr:title>Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1848ae36826f5056bb883025138472a1"><gtr:id>1848ae36826f5056bb883025138472a1</gtr:id><gtr:otherNames>Silber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>F641A36900A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51A8D1D0-BA01-4995-A5A6-4FE8EC02C5DD</gtr:id><gtr:title>Stunning, hibernation, and assessment of myocardial viability.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>D77FDCCA7D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF1BEF35-A85D-4A0E-B930-B82D6763F8A7</gtr:id><gtr:title>A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2afcb1bcd1c915ee118fd6ad0fb3f637"><gtr:id>2afcb1bcd1c915ee118fd6ad0fb3f637</gtr:id><gtr:otherNames>Coppen SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>C5486D8C60A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4983565-63A6-4E80-8F68-73F51E3F058C</gtr:id><gtr:title>Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63306636ddfe75756e73695a0462fa41"><gtr:id>63306636ddfe75756e73695a0462fa41</gtr:id><gtr:otherNames>Recio-Mayoral A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>A8730483DFE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>131185E3-56BA-4775-A6A7-C8AF7B66BF9C</gtr:id><gtr:title>Quantification of subendocardial and subepicardial blood flow using 15O-labeled water and PET: experimental validation.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bf11c5f76c80a0a4f89bfc3473737a5"><gtr:id>3bf11c5f76c80a0a4f89bfc3473737a5</gtr:id><gtr:otherNames>Rimoldi O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>1626723A65A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1666645-37AB-4F33-BE49-83C1EA460B4F</gtr:id><gtr:title>The young mouse heart is composed of myocytes heterogeneous in age and function.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c98c4078cae4b0752d83b16c2e5f79df"><gtr:id>c98c4078cae4b0752d83b16c2e5f79df</gtr:id><gtr:otherNames>Rota M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>D9B7E7380DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D907AA06-E2F0-47E8-BFA0-CE0B6CA44965</gtr:id><gtr:title>123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e55a5b5cf9b7c22e2e51461912d0dd74"><gtr:id>e55a5b5cf9b7c22e2e51461912d0dd74</gtr:id><gtr:otherNames>Jacobson AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1071-3581</gtr:issn><gtr:outcomeId>B66F18D008D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F346A964-65AC-4234-BFA7-61402CE9EAE1</gtr:id><gtr:title>[Guidelines for percutaneous coronary interventions].</gtr:title><gtr:parentPublicationTitle>Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1848ae36826f5056bb883025138472a1"><gtr:id>1848ae36826f5056bb883025138472a1</gtr:id><gtr:otherNames>Silber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1129-4728</gtr:issn><gtr:outcomeId>45D362813FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2087C18-06A2-46E3-B37F-17AD17096EC6</gtr:id><gtr:title>Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50c095d08d149ac6b63be5b1d14180bd"><gtr:id>50c095d08d149ac6b63be5b1d14180bd</gtr:id><gtr:otherNames>Sotgia B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>932C804D1E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2166AF37-4FCE-4485-86CC-D9584E79DFAB</gtr:id><gtr:title>Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41afb0027f4395260c07d361c2658835"><gtr:id>41afb0027f4395260c07d361c2658835</gtr:id><gtr:otherNames>Elliott PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>3C0221AC22C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D85A22D-A802-4DFB-96DC-A778442F050E</gtr:id><gtr:title>Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/999ff6d32c66303bc88979aae30c4c70"><gtr:id>999ff6d32c66303bc88979aae30c4c70</gtr:id><gtr:otherNames>Kaufmann PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>2BC8D5290EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>271F169A-F2FF-4498-9E17-B04119A10D30</gtr:id><gtr:title>Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66e42708c02a833015bb7124c42723ae"><gtr:id>66e42708c02a833015bb7124c42723ae</gtr:id><gtr:otherNames>Jagathesan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>6E55E331C34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3C10C8B-9316-4832-83E2-93EA5B53F998</gtr:id><gtr:title>Coronary recanalisation, myocardial viability, and ventricular remodelling after infarction.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>B1FD9941E48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>674EF9D3-B857-4394-86AA-530C470D216A</gtr:id><gtr:title>A common system for the comprehension and production of narrative speech.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67f975a178c3ed442ad5ad6e7db6f1a7"><gtr:id>67f975a178c3ed442ad5ad6e7db6f1a7</gtr:id><gtr:otherNames>Awad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>6903A5A7129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C297493A-5517-465A-9C30-9FCCD073FA59</gtr:id><gtr:title>Rigid-body transformation of list-mode projection data for respiratory motion correction in cardiac PET.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb13b928b3847b5b840d9257e07f58bd"><gtr:id>eb13b928b3847b5b840d9257e07f58bd</gtr:id><gtr:otherNames>Livieratos L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn><gtr:outcomeId>A843114B345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCD61A63-2EB9-4AA7-BA7D-D72C997BF3CF</gtr:id><gtr:title>Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d20456365d8ce30c0063e027ed45c87"><gtr:id>2d20456365d8ce30c0063e027ed45c87</gtr:id><gtr:otherNames>Sciagr? R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1071-3581</gtr:issn><gtr:outcomeId>032E31DC14A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AABAD4E-FD83-4FC2-882F-DFDBBAAE557E</gtr:id><gtr:title>Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcd0a3e1c9bc8308f5df54fd0b1419fb"><gtr:id>bcd0a3e1c9bc8308f5df54fd0b1419fb</gtr:id><gtr:otherNames>Fukushima S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>ACA9BBA1926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84F2605B-8313-4B22-ADA9-1366F34A453E</gtr:id><gtr:title>A vascular ring without compression: double aortic arch presenting as a coincidental finding during cardiac catheterisation.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd52aa71177aa58f9e3c17caa8f1af0a"><gtr:id>bd52aa71177aa58f9e3c17caa8f1af0a</gtr:id><gtr:otherNames>Kindler H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>C16F5D7D460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76D5A516-2AD5-4F4B-8770-8A8C904366F1</gtr:id><gtr:title>Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow.</gtr:title><gtr:parentPublicationTitle>Clinical journal of the American Society of Nephrology : CJASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35b44c5bf9a1f88a6faeda7c31806f16"><gtr:id>35b44c5bf9a1f88a6faeda7c31806f16</gtr:id><gtr:otherNames>McIntyre CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1555-9041</gtr:issn><gtr:outcomeId>A0BB962B31C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8B32FD0-B82C-4B37-B038-E0D4FCFA651E</gtr:id><gtr:title>Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0257b5af0b0b78392b5f54ba2697d41f"><gtr:id>0257b5af0b0b78392b5f54ba2697d41f</gtr:id><gtr:otherNames>Wyss CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>057BAF1B9B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A2CB084-6434-4318-BA5E-36534B85E86B</gtr:id><gtr:title>Basal and hyperaemic myocardial blood flow in regionally denervated canine hearts: an in vivo study with positron emission tomography.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1170e3a78eba7bd406bfd603bf9bed49"><gtr:id>1170e3a78eba7bd406bfd603bf9bed49</gtr:id><gtr:otherNames>Rimoldi OE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>DC64776C473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72B99790-5FC0-4969-969A-8DCC2EB903AE</gtr:id><gtr:title>Coronary microvascular resistance: methods for its quantification in humans.</gtr:title><gtr:parentPublicationTitle>Basic research in cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5a882d5f29ecf357f9ee63f74e125b"><gtr:id>ec5a882d5f29ecf357f9ee63f74e125b</gtr:id><gtr:otherNames>Knaapen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-8428</gtr:issn><gtr:outcomeId>5DF66045412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>613917EF-8C12-421C-9B79-CD779D823E1F</gtr:id><gtr:title>Evaluation of the microcirculation in hypertension and cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe57f7c91bf2f4302fbb7dc79204ce5c"><gtr:id>fe57f7c91bf2f4302fbb7dc79204ce5c</gtr:id><gtr:otherNames>Struijker-Boudier HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>6187376EC86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F97CFA54-8C28-4D20-AF9F-BE438AFC4A73</gtr:id><gtr:title>Quantification of [11C]GB67 binding to cardiac alpha1-adrenoceptors with positron emission tomography: validation in pigs.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c65790dc949ee52bb22e8062d9ddd91"><gtr:id>8c65790dc949ee52bb22e8062d9ddd91</gtr:id><gtr:otherNames>Park-Holohan SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>4DC9F3F354B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>069B3FA9-8417-4200-B461-222B9D0F6A21</gtr:id><gtr:title>Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis.</gtr:title><gtr:parentPublicationTitle>American journal of kidney diseases : the official journal of the National Kidney Foundation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87395663217cd17870e73d78a444c7ec"><gtr:id>87395663217cd17870e73d78a444c7ec</gtr:id><gtr:otherNames>Selby NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0272-6386</gtr:issn><gtr:outcomeId>1BA0C2AC942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>629806BF-8F9A-416C-8956-BA25DC6C2F52</gtr:id><gtr:title>Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7771ec39b9bd63d704f50fabca5f24ae"><gtr:id>7771ec39b9bd63d704f50fabca5f24ae</gtr:id><gtr:otherNames>Chen X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>63908963AD0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>445DB0DF-905E-4157-ACDB-2D48E729E631</gtr:id><gtr:title>Impairment of coronary flow reserve in aortic stenosis.</gtr:title><gtr:parentPublicationTitle>Journal of applied physiology (Bethesda, Md. : 1985)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ed80e28570cff812b4f55abd026eb14"><gtr:id>5ed80e28570cff812b4f55abd026eb14</gtr:id><gtr:otherNames>Garcia D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0161-7567</gtr:issn><gtr:outcomeId>84A52461F3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>128AA70F-B747-45F7-A2AE-8EEA052DDE1E</gtr:id><gtr:title>Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc78d7d0c6c51fa46d6dd8652192ffdb"><gtr:id>bc78d7d0c6c51fa46d6dd8652192ffdb</gtr:id><gtr:otherNames>Doehner W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn><gtr:outcomeId>9B296802854</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>739034D3-A8D9-4F28-844C-0288A96613E9</gtr:id><gtr:title>Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a657f6fdce24adedd97579e83b5680cb"><gtr:id>a657f6fdce24adedd97579e83b5680cb</gtr:id><gtr:otherNames>Tansley P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1053-2498</gtr:issn><gtr:outcomeId>50AF072ED9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37F2E301-EC02-4E65-AB6B-A843C3D9D497</gtr:id><gtr:title>Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences.</gtr:title><gtr:parentPublicationTitle>Italian heart journal : official journal of the Italian Federation of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/282b7ca6ec2c94a0461b974eed69ef13"><gtr:id>282b7ca6ec2c94a0461b974eed69ef13</gtr:id><gtr:otherNames>Olivotto I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1129-471X</gtr:issn><gtr:outcomeId>F06E6694008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>532D854B-5840-4430-9977-8D45534E7547</gtr:id><gtr:title>Radionuclide PET and PET/CT in coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bbf940badd8dc84ecb8bd0cb119f0f1"><gtr:id>2bbf940badd8dc84ecb8bd0cb119f0f1</gtr:id><gtr:otherNames>Neglia D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>B20157412E9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>621F0F1D-49F0-4B1E-9056-05FE9B1DB7C1</gtr:id><gtr:title>Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729f24b3670b863ab7f2a80301175bc3"><gtr:id>729f24b3670b863ab7f2a80301175bc3</gtr:id><gtr:otherNames>Fox K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>93018CF1924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F47D167-5ED6-4932-A4F0-93276ADE760C</gtr:id><gtr:title>Is the chest pain in cardiac syndrome X due to subendocardial ischaemia?</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>3AA1880C6D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E944DCD5-7930-4DC7-ABAD-70643D0388BB</gtr:id><gtr:title>Dobutamine-induced hyperaemia inversely correlates with coronary artery stenosis severity and highlights dissociation between myocardial blood flow and oxygen consumption.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66e42708c02a833015bb7124c42723ae"><gtr:id>66e42708c02a833015bb7124c42723ae</gtr:id><gtr:otherNames>Jagathesan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>4A4B5AFE0E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5B2C8B0-CD64-4789-B219-8B438E0023A0</gtr:id><gtr:title>Myocardial ischaemia and metabolic memory.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>E6D93D66ABE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A7EE9F0-E3C0-4A59-9316-995D0AF5E922</gtr:id><gtr:title>Cardiovascular effects of methamphetamine in Parkinson's disease patients.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>C816BBD957C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1506AB2-6CDE-44E4-BF94-02C6A178E09D</gtr:id><gtr:title>Coronary microvascular remodeling and ischaemia in hypertension</gtr:title><gtr:parentPublicationTitle>American Journal of Cardiovascular Drugs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b936dc87d19be2b11ad51ff9f618fa09"><gtr:id>b936dc87d19be2b11ad51ff9f618fa09</gtr:id><gtr:otherNames>Camici P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:outcomeId>C69629C36F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5610088-F5A7-4DF9-8C71-1CF1BA2D7EB5</gtr:id><gtr:title>Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts?</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4e1337e64fb7dbfb0eedf2c238694d8"><gtr:id>a4e1337e64fb7dbfb0eedf2c238694d8</gtr:id><gtr:otherNames>Bax JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>D99563F1D65</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA31FBBB-770A-4F61-A7CF-116376BFCE59</gtr:id><gtr:title>Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Heart and circulatory physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5a882d5f29ecf357f9ee63f74e125b"><gtr:id>ec5a882d5f29ecf357f9ee63f74e125b</gtr:id><gtr:otherNames>Knaapen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0363-6135</gtr:issn><gtr:outcomeId>096FD5123EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0F6C886-C139-4104-9090-55D621786BCF</gtr:id><gtr:title>Coronary microvascular dysfunction.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>DF9D240FEAB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AB21E4E-83CE-44B6-9F9A-A7A953EC853D</gtr:id><gtr:title>Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fc78bcab9ecfd212f8a1182e883e166"><gtr:id>3fc78bcab9ecfd212f8a1182e883e166</gtr:id><gtr:otherNames>Dutka DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>28D8D1B7EF5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>022D1702-5DA6-4E8E-9668-17EF909DF350</gtr:id><gtr:title>Guidelines for percutaneous coronary interventions: reply</gtr:title><gtr:parentPublicationTitle>European Heart Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1848ae36826f5056bb883025138472a1"><gtr:id>1848ae36826f5056bb883025138472a1</gtr:id><gtr:otherNames>Silber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>C0571E5C3EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>867ED72C-144D-4512-B562-C68967AC0957</gtr:id><gtr:title>Coronary microvascular dysfunction in patients with cardiomyopathies.</gtr:title><gtr:parentPublicationTitle>Circulation. Heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1941-3289</gtr:issn><gtr:outcomeId>3E6AC9B35D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD655340-4520-4399-B573-E1125F5EFE54</gtr:id><gtr:title>[Guidelines on the management of stable angina pectoris: executive summary].</gtr:title><gtr:parentPublicationTitle>Giornale italiano di cardiologia (2006)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0a96793cee743faf333c7bcf6ca036c"><gtr:id>e0a96793cee743faf333c7bcf6ca036c</gtr:id><gtr:otherNames>Task Force per il Trattamento dell'Angina Pectoris Stabile della Societ? Europea di Cardiologia</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1827-6806</gtr:issn><gtr:outcomeId>16F15201603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24EAD98F-DD75-4547-B5A3-B9DEAB7A7C14</gtr:id><gtr:title>[Guidelines on the management of stable angina pectoris. Executive summary].</gtr:title><gtr:parentPublicationTitle>Revista espanola de cardiologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729f24b3670b863ab7f2a80301175bc3"><gtr:id>729f24b3670b863ab7f2a80301175bc3</gtr:id><gtr:otherNames>Fox K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-8932</gtr:issn><gtr:outcomeId>9A9C5D2D81C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54917D7A-BE63-4EAC-A43E-2912DD9F45A1</gtr:id><gtr:title>Advances in coronary microvascular dysfunction.</gtr:title><gtr:parentPublicationTitle>Heart, lung &amp; circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/753e4b55c5279643ae9d8b2a8af6a62f"><gtr:id>753e4b55c5279643ae9d8b2a8af6a62f</gtr:id><gtr:otherNames>Beltrame JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1443-9506</gtr:issn><gtr:outcomeId>4DE5BC5E403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E599995B-5ECC-4EA6-BE40-3A512458FFE1</gtr:id><gtr:title>Absolute figures are better than percentages.</gtr:title><gtr:parentPublicationTitle>JACC. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5135226dff29ae001b99a3e05d41ba4"><gtr:id>e5135226dff29ae001b99a3e05d41ba4</gtr:id><gtr:otherNames>Camici PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1876-7591</gtr:issn><gtr:outcomeId>24F6604D138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E782CE7B-E901-4DBE-8A40-1C084D090D34</gtr:id><gtr:title>List-mode-based reconstruction for respiratory motion correction in PET using non-rigid body transformations.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db766c6692935a7cfce5e74998db476e"><gtr:id>db766c6692935a7cfce5e74998db476e</gtr:id><gtr:otherNames>Lamare F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn><gtr:outcomeId>28AD5B3199C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCE70CCC-6774-47F9-A1DA-84232E40AEE9</gtr:id><gtr:title>Is central nervous system processing altered in patients with heart failure?</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/531befaf40e2638cc520cd4a6183dafd"><gtr:id>531befaf40e2638cc520cd4a6183dafd</gtr:id><gtr:otherNames>Rosen SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>6452517E9A0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F62A1C37-EC22-4287-B0B3-33C23EEF49EB</gtr:id><gtr:title>Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: A substudy of the persantine in stable angina (PISA) study.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66e42708c02a833015bb7124c42723ae"><gtr:id>66e42708c02a833015bb7124c42723ae</gtr:id><gtr:otherNames>Jagathesan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0160-2446</gtr:issn><gtr:outcomeId>F2AEB23F6ED</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U120084164</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>